These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1924461)

  • 1. Iridium-192 implants in patients with large stage C prostate cancer.
    Brosman SA
    Prog Clin Biol Res; 1991; 370():281-90. PubMed ID: 1924461
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined iridium 192 afterloading therapy of prostate carcinoma].
    Dinges S; Loening SA; Budach V
    Praxis (Bern 1994); 1997 Nov; 86(48):1908-11. PubMed ID: 9480511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External beam irradiation combined with the use of 192-iridium implants and radiofrequency-induced hyperthermia in the treatment of prostatic carcinoma.
    Bagshaw MA; Prionas SD; Goffinet DR; Cox RS; Kapp DS; Freiha F
    Prog Clin Biol Res; 1991; 370():275-9. PubMed ID: 1924460
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four year clinical statistics of iridium-192 high dose rate brachytherapy.
    Shigehara K; Mizokami A; Komatsu K; Koshida K; Namiki M
    Int J Urol; 2006 Feb; 13(2):116-21. PubMed ID: 16563134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is radiotherapy of use in stage C prostate cancer?
    Porter AT
    Prog Clin Biol Res; 1989; 303():211-8. PubMed ID: 2674986
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
    Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
    Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brachytherapy in prostatic adenocarcinoma].
    Haie-Meder C; Court B; Perrin JL; Wibault P; Lartigau E; Gerbaulet A
    Ann Urol (Paris); 1994; 28(6-7):295-301. PubMed ID: 7893114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
    Martinez A; Gonzalez J; Spencer W; Gustafson G; Kestin L; Kearney D; Vicini FA
    J Urol; 2003 Mar; 169(3):974-9; discussion 979-80. PubMed ID: 12576825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
    Lee WR; Pollack A; Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Paryani SB; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1413-8. PubMed ID: 11037556
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiotherapy of prostate cancer].
    Knüfermann H; Wannenmacher M
    Urologe A; 1986 Jan; 25(1):18-22. PubMed ID: 3962039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iridium-192 brachytherapy in the treatment of cancer of the prostate.
    Donnelly BJ; Pedersen JE; Porter AT; McPhee MS
    Urol Clin North Am; 1991 Aug; 18(3):481-3. PubMed ID: 1877110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Tseng TY; Sevilla DW; Moul JW; Maloney KE
    Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial irradiation for localized prostate cancer.
    Herr HW
    Semin Urol; 1983 Aug; 1(3):222-8. PubMed ID: 6379805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.